NMRA

Quote

Short

News

Articles

Message Board

Outperform Recommendation Issued On NMRA By William Blair

February 17, 2026 06:15:08 am

Source: KlickAnalytics

2026-02-17 06:15:08 ET

William Blair analyst issues OUTPERFORM recommendation for NMRA on February 17, 2026 11:00AM ET.

The previous analyst recommendation was Market Perform.

NMRA was trading at $3.2 at issue of the analyst recommendation.

The overall analyst consensus : BUY.

Current analyst recommendations are : 5 - Buy, 1 - Hold, 2 - Sell recommendations .

Historical Analyst Recommendations

Latest 10 ...
Full story available on KlickAnalytics.com

Neumora Therapeutics Inc.

NASDAQ: NMRA

NMRA Trading

0.0% G/L:

$3.545 Last:

221,326 Volume:

$3.50 Open:

mwn-ir Ad 300

NMRA Latest News

February 17, 2026 06:15:08 am

Outperform Recommendation Issued On NMRA By William Blair

February 04, 2026 07:00:00 am

Neumora Therapeutics to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026

January 05, 2026 06:35:00 am

Neumora Therapeutics Highlights 2026 Pipeline Strategy and Anticipated Upcoming Milestones

January 05, 2026 06:30:00 am

Neumora Therapeutics Announces Positive Results from NMRA-511 Phase 1b Signal-Seeking Study in Alzheimer's Disease Agitation

NMRA Stock Data

Market Cap $499,596,451

Float 52,800,160

Insiders Ownership 10.86%

Institutions 30

Short Percent N/A

Industry Biotechnology & Life Sciences

Sector Healthcare

Website https://neumoratx.com

Country US

City Watertown

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App